VIVUS Inc (NASDAQ:VVUS)

0.9346
Delayed Data
As of May 24
 +0.0496 / +5.60%
Today’s Change
0.33
Today|||52-Week Range
1.38
+85.95%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$57.1M

Company Description

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. Its products include Qsymia and STENDRA/SPEDRA. The company was founded by Virgil A. Palace in April 16, 1991 and is headquartered in Mountain View, CA.

Contact Information

VIVUS, Inc.
900 East Evelyn Avenue
Campbell California 95008
P:(650) 934-5200
Investor Relations:

Employees

Shareholders

Mutual fund holders5.25%
Individual stakeholders25.91%
Other institutional16.02%

Top Executives

John P. AmosChief Executive Officer & Director
Thomas Braxton KingPresident & Independent Director
Scott OehrleinChief Operating Officer
Mark K. OkiChief Financial & Accounting Officer
Santosh T. VargheseChief Medical Officer